IncFact
Company Profiles: Revenue, Growth, Competition

XOMA Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Xoma

Access the complete profile.

Xoma Fast Facts

Revenue$10 - $50 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
Address2200 Powell Street
Emeryville, CA 94608

www.xoma.com


Xoma's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Xoma's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Xoma is a publicly traded company on NGM using the ticker symbol XOMA. Detailed information on company financials and operating reports can be found here: NGM: XOMA



Xoma Annual Revenue and Growth Rate

Xoma Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Xoma's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Xoma is developing and marketing. Xoma doesn't have any recent trademark applications, indicating Xoma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
AEROPREX
pharmaceutical products, namely, pharmaceutical preparations for use in pulmonary applications
01/08/1998
MYCOPREX
antifungal preparations for human use only
12/15/1995
I-PREX
pharmaceutical products, namely pharmaceutical products for use in ophthalmologic applications
11/14/1995

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Xoma grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Xoma is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Xoma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Xoma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
TMUNITY THERAPEUTICSPhiladelphia, PA56 




Nearby Competitors

These companies are similar in business line and location to Xoma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
AMYRISEmeryville, CA100 
ADAMAS PHARMACEUTICALSEmeryville, CA33 
SANTEN HOLDINGS USEmeryville, CA33 
NOVABAY PHARMACEUTICALSEmeryville, CA10 
XOMAEmeryville, CA8 
SOUND AGRICULTUREEmeryville, CA4 




Future Competition: Xoma's Fastest Growing Competitors

These companies are in the same general field as Xoma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Xoma Competitors